2012
The cost-effectiveness of rapid HIV testing in substance abuse treatment: Results of a randomized trial
Schackman BR, Metsch LR, Colfax GN, Leff JA, Wong A, Scott CA, Feaster DJ, Gooden L, Matheson T, Haynes LF, Paltiel AD, Walensky RP. The cost-effectiveness of rapid HIV testing in substance abuse treatment: Results of a randomized trial. Drug And Alcohol Dependence 2012, 128: 90-97. PMID: 22971593, PMCID: PMC3546145, DOI: 10.1016/j.drugalcdep.2012.08.009.Peer-Reviewed Original ResearchMeSH KeywordsAdultCost-Benefit AnalysisFemaleHealth Care CostsHIV InfectionsHumansMaleMass ScreeningMiddle AgedPrevalenceQuality-Adjusted Life YearsSubstance-Related DisordersConceptsQuality-adjusted life yearsSubstance abuse treatment programsNational HIV/AIDS StrategyCost-effectiveness ratioCommunity-based substance abuse treatment programsUndiagnosed HIV prevalenceRisk reduction counselingRapid HIV testingTreatment programHIV testingHIV prevalenceSite rapid testingSite rapid HIV testingHIV risk reduction counselingHIV/AIDS StrategyIncremental cost-effectiveness ratioHIV testing strategiesLife expectancyHIV testing offerPrior testing historyReceipt of resultsSubstance abuse treatmentRapid testingHIV screeningPatient demographics
2007
Social costs of robbery and the cost‐effectiveness of substance abuse treatment
Basu A, Paltiel AD, Pollack HA. Social costs of robbery and the cost‐effectiveness of substance abuse treatment. Health Economics 2007, 17: 927-946. PMID: 17992708, PMCID: PMC3512566, DOI: 10.1002/hec.1305.Peer-Reviewed Original Research